Microarray patch transdermal drug delivery systems consist of tiny protrusions that stick to the body like small bandages that painlessly penetrate the outermost layer of the skin to deliver the drug or vaccine to the top layer of the skin. This drug delivery system is simpler than traditional drug delivery methods and can also reduce a certain risk of infection, ensuring the safety of patients.
The global Microarray Patch Transdermal Drug Delivery Systems market was valued at US$ 5615 million in 2023 and is anticipated to reach US$ 8345 million by 2030, witnessing a CAGR of 6.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Microarray Patch Transdermal Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microarray Patch Transdermal Drug Delivery Systems.
Report Scope
The Microarray Patch Transdermal Drug Delivery Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Microarray Patch Transdermal Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microarray Patch Transdermal Drug Delivery Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
3M
Becton
Endoderma
BD
Raphas
Nanopass Tech
Corium International
Nitto Denko
Microdermics
TheraJect
Vaxxas
KINDEVA
QuadMedicine
Lohmann Therapie-Systeme
AdminMed Nano BioSciences
Segment by Type
Solid Microneedles
Hollow Microneedles
Dissolving Microneedles
Segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Microarray Patch Transdermal Drug Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Microarray Patch Transdermal Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Microarray Patch Transdermal Drug Delivery Systems Market Overview
1.1 Product Overview and Scope of Microarray Patch Transdermal Drug Delivery Systems
1.2 Microarray Patch Transdermal Drug Delivery Systems Segment by Type
1.2.1 Global Microarray Patch Transdermal Drug Delivery Systems Market Value Comparison by Type (2024-2030)
1.2.2 Solid Microneedles
1.2.3 Hollow Microneedles
1.2.4 Dissolving Microneedles
1.3 Microarray Patch Transdermal Drug Delivery Systems Segment by Application
1.3.1 Global Microarray Patch Transdermal Drug Delivery Systems Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Global Microarray Patch Transdermal Drug Delivery Systems Market Size Estimates and Forecasts
1.4.1 Global Microarray Patch Transdermal Drug Delivery Systems Revenue 2019-2030
1.4.2 Global Microarray Patch Transdermal Drug Delivery Systems Sales 2019-2030
1.4.3 Global Microarray Patch Transdermal Drug Delivery Systems Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Microarray Patch Transdermal Drug Delivery Systems Market Competition by Manufacturers
2.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Manufacturers (2019-2024)
2.2 Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Microarray Patch Transdermal Drug Delivery Systems Average Price by Manufacturers (2019-2024)
2.4 Global Microarray Patch Transdermal Drug Delivery Systems Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Microarray Patch Transdermal Drug Delivery Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Microarray Patch Transdermal Drug Delivery Systems, Product Type & Application
2.7 Microarray Patch Transdermal Drug Delivery Systems Market Competitive Situation and Trends
2.7.1 Microarray Patch Transdermal Drug Delivery Systems Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Microarray Patch Transdermal Drug Delivery Systems Players Market Share by Revenue
2.7.3 Global Microarray Patch Transdermal Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Microarray Patch Transdermal Drug Delivery Systems Retrospective Market Scenario by Region
3.1 Global Microarray Patch Transdermal Drug Delivery Systems Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Microarray Patch Transdermal Drug Delivery Systems Global Microarray Patch Transdermal Drug Delivery Systems Sales by Region: 2019-2030
3.2.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales by Region: 2019-2024
3.2.2 Global Microarray Patch Transdermal Drug Delivery Systems Sales by Region: 2025-2030
3.3 Global Microarray Patch Transdermal Drug Delivery Systems Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Region: 2019-2030
3.3.1 Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Region: 2019-2024
3.3.2 Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Region: 2025-2030
3.4 North America Microarray Patch Transdermal Drug Delivery Systems Market Facts & Figures by Country
3.4.1 North America Microarray Patch Transdermal Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Microarray Patch Transdermal Drug Delivery Systems Sales by Country (2019-2030)
3.4.3 North America Microarray Patch Transdermal Drug Delivery Systems Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Microarray Patch Transdermal Drug Delivery Systems Market Facts & Figures by Country
3.5.1 Europe Microarray Patch Transdermal Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Microarray Patch Transdermal Drug Delivery Systems Sales by Country (2019-2030)
3.5.3 Europe Microarray Patch Transdermal Drug Delivery Systems Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Microarray Patch Transdermal Drug Delivery Systems Market Facts & Figures by Country
3.6.1 Asia Pacific Microarray Patch Transdermal Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Microarray Patch Transdermal Drug Delivery Systems Sales by Country (2019-2030)
3.6.3 Asia Pacific Microarray Patch Transdermal Drug Delivery Systems Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Microarray Patch Transdermal Drug Delivery Systems Market Facts & Figures by Country
3.7.1 Latin America Microarray Patch Transdermal Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Microarray Patch Transdermal Drug Delivery Systems Sales by Country (2019-2030)
3.7.3 Latin America Microarray Patch Transdermal Drug Delivery Systems Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Microarray Patch Transdermal Drug Delivery Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Microarray Patch Transdermal Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Microarray Patch Transdermal Drug Delivery Systems Sales by Country (2019-2030)
3.8.3 Middle East and Africa Microarray Patch Transdermal Drug Delivery Systems Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales by Type (2019-2030)
4.1.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales by Type (2019-2024)
4.1.2 Global Microarray Patch Transdermal Drug Delivery Systems Sales by Type (2025-2030)
4.1.3 Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Type (2019-2030)
4.2 Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Type (2019-2030)
4.2.1 Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Type (2019-2024)
4.2.2 Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Type (2025-2030)
4.2.3 Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Type (2019-2030)
4.3 Global Microarray Patch Transdermal Drug Delivery Systems Price by Type (2019-2030)
5 Segment by Application
5.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales by Application (2019-2030)
5.1.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales by Application (2019-2024)
5.1.2 Global Microarray Patch Transdermal Drug Delivery Systems Sales by Application (2025-2030)
5.1.3 Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Application (2019-2030)
5.2 Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Application (2019-2030)
5.2.1 Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Application (2019-2024)
5.2.2 Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Application (2025-2030)
5.2.3 Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Application (2019-2030)
5.3 Global Microarray Patch Transdermal Drug Delivery Systems Price by Application (2019-2030)
6 Key Companies Profiled
6.1 3M
6.1.1 3M Corporation Information
6.1.2 3M Description and Business Overview
6.1.3 3M Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.1.4 3M Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.1.5 3M Recent Developments/Updates
6.2 Becton
6.2.1 Becton Corporation Information
6.2.2 Becton Description and Business Overview
6.2.3 Becton Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Becton Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.2.5 Becton Recent Developments/Updates
6.3 Endoderma
6.3.1 Endoderma Corporation Information
6.3.2 Endoderma Description and Business Overview
6.3.3 Endoderma Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Endoderma Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.3.5 Endoderma Recent Developments/Updates
6.4 BD
6.4.1 BD Corporation Information
6.4.2 BD Description and Business Overview
6.4.3 BD Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BD Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.4.5 BD Recent Developments/Updates
6.5 Raphas
6.5.1 Raphas Corporation Information
6.5.2 Raphas Description and Business Overview
6.5.3 Raphas Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Raphas Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.5.5 Raphas Recent Developments/Updates
6.6 Nanopass Tech
6.6.1 Nanopass Tech Corporation Information
6.6.2 Nanopass Tech Description and Business Overview
6.6.3 Nanopass Tech Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Nanopass Tech Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.6.5 Nanopass Tech Recent Developments/Updates
6.7 Corium International
6.6.1 Corium International Corporation Information
6.6.2 Corium International Description and Business Overview
6.6.3 Corium International Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Corium International Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.7.5 Corium International Recent Developments/Updates
6.8 Nitto Denko
6.8.1 Nitto Denko Corporation Information
6.8.2 Nitto Denko Description and Business Overview
6.8.3 Nitto Denko Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Nitto Denko Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.8.5 Nitto Denko Recent Developments/Updates
6.9 Microdermics
6.9.1 Microdermics Corporation Information
6.9.2 Microdermics Description and Business Overview
6.9.3 Microdermics Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Microdermics Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.9.5 Microdermics Recent Developments/Updates
6.10 TheraJect
6.10.1 TheraJect Corporation Information
6.10.2 TheraJect Description and Business Overview
6.10.3 TheraJect Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.10.4 TheraJect Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.10.5 TheraJect Recent Developments/Updates
6.11 Vaxxas
6.11.1 Vaxxas Corporation Information
6.11.2 Vaxxas Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
6.11.3 Vaxxas Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Vaxxas Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.11.5 Vaxxas Recent Developments/Updates
6.12 KINDEVA
6.12.1 KINDEVA Corporation Information
6.12.2 KINDEVA Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
6.12.3 KINDEVA Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.12.4 KINDEVA Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.12.5 KINDEVA Recent Developments/Updates
6.13 QuadMedicine
6.13.1 QuadMedicine Corporation Information
6.13.2 QuadMedicine Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
6.13.3 QuadMedicine Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.13.4 QuadMedicine Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.13.5 QuadMedicine Recent Developments/Updates
6.14 Lohmann Therapie-Systeme
6.14.1 Lohmann Therapie-Systeme Corporation Information
6.14.2 Lohmann Therapie-Systeme Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
6.14.3 Lohmann Therapie-Systeme Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Lohmann Therapie-Systeme Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.14.5 Lohmann Therapie-Systeme Recent Developments/Updates
6.15 AdminMed Nano BioSciences
6.15.1 AdminMed Nano BioSciences Corporation Information
6.15.2 AdminMed Nano BioSciences Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
6.15.3 AdminMed Nano BioSciences Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.15.4 AdminMed Nano BioSciences Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.15.5 AdminMed Nano BioSciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Microarray Patch Transdermal Drug Delivery Systems Industry Chain Analysis
7.2 Microarray Patch Transdermal Drug Delivery Systems Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Microarray Patch Transdermal Drug Delivery Systems Production Mode & Process
7.4 Microarray Patch Transdermal Drug Delivery Systems Sales and Marketing
7.4.1 Microarray Patch Transdermal Drug Delivery Systems Sales Channels
7.4.2 Microarray Patch Transdermal Drug Delivery Systems Distributors
7.5 Microarray Patch Transdermal Drug Delivery Systems Customers
8 Microarray Patch Transdermal Drug Delivery Systems Market Dynamics
8.1 Microarray Patch Transdermal Drug Delivery Systems Industry Trends
8.2 Microarray Patch Transdermal Drug Delivery Systems Market Drivers
8.3 Microarray Patch Transdermal Drug Delivery Systems Market Challenges
8.4 Microarray Patch Transdermal Drug Delivery Systems Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
3M
Becton
Endoderma
BD
Raphas
Nanopass Tech
Corium International
Nitto Denko
Microdermics
TheraJect
Vaxxas
KINDEVA
QuadMedicine
Lohmann Therapie-Systeme
AdminMed Nano BioSciences
听
听
*If Applicable.
